Nova (NVMI) Cash & Equivalents (2009 - 2025)

Nova has disclosed Cash & Equivalents across 17 years of filings, most recently posting $214.5 million for Q4 2025.

• On a quarterly basis, Cash & Equivalents rose 35.93% year-over-year to $214.5 million in Q4 2025; TTM through Dec 2025 was $214.5 million, a 35.93% increase from a year earlier, with the FY2025 full-year figure at $214.8 million, up 36.13% from the prior year.
• Cash & Equivalents came in at $214.5 million for Q4 2025 at Nova, down from $522.0 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $522.0 million in Q3 2025 and troughed at $72.1 million in Q3 2021.
• Historically, Cash & Equivalents has averaged $161.1 million across 5 years, with a median of $133.3 million in 2021.
• Peak annual rise in Cash & Equivalents reached 487.54% in 2021, while the deepest fall reached 45.46% in 2021.
• Nova's Cash & Equivalents stood at $126.7 million in 2021, then changed by 0.0% to $126.7 million in 2022, then fell by 8.06% to $116.5 million in 2023, then soared by 35.46% to $157.8 million in 2024, then soared by 35.93% to $214.5 million in 2025.
• The last three Cash & Equivalents figures came in at $214.5 million (Q4 2025), $522.0 million (Q3 2025), and $160.9 million (Q2 2025), per Business Quant data.